|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
41,560,000 |
Market
Cap: |
260.58(M) |
Last
Volume: |
5,200 |
Avg
Vol: |
5,186 |
52
Week Range: |
$3.61 - $10.69 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Axogen is focused on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Co.'s platform for peripheral nerve repair features a portfolio of products, including Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; and Axoguard Nerve Connector, a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Co. also provides Axotouch Two-Point Discriminator, which is used to measure the innervation density of any surface area of the skin.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
30,000 |
30,000 |
Total Buy Value |
$0 |
$0 |
$188,940 |
$188,940 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
3 |
Total Shares Sold |
118,082 |
130,582 |
172,562 |
368,410 |
Total Sell Value |
$980,899 |
$1,074,708 |
$1,440,488 |
$3,484,755 |
Total People Sold |
5 |
6 |
6 |
6 |
Total Sell Transactions |
6 |
7 |
8 |
21 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mccarrey Shawn F |
SVP of Sales |
|
2015-02-10 |
4 |
A |
$2.75 |
$12,100 |
D/D |
4,400 |
34,400 |
|
- |
|
Freitag Gregory Gene |
General Counsel |
|
2015-02-10 |
4 |
A |
$2.75 |
$13,200 |
D/D |
4,800 |
48,902 |
|
- |
|
Deerfield Special Situations Fund, L.p. |
10% Owner |
|
2015-02-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,870,824 |
|
- |
|
Mandato Joseph M |
Director |
|
2014-12-11 |
4 |
S |
$3.15 |
$7,377 |
I/I |
(2,342) |
1,376,392 |
|
- |
|
Mandato Joseph M |
Director |
|
2014-12-10 |
4 |
S |
$3.06 |
$145,714 |
I/I |
(47,658) |
1,378,734 |
|
- |
|
Johnston Lee Robert Jr |
Chief Financial Officer |
|
2014-12-10 |
4 |
B |
$3.06 |
$30,600 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
Mandato Joseph M |
Director |
|
2014-12-01 |
4 |
A |
$2.94 |
$17,640 |
D/D |
6,000 |
43,500 |
|
- |
|
Gold Mark Stephen |
Director |
|
2014-09-30 |
4 |
OE |
$1.07 |
$310 |
D/D |
290 |
303,261 |
|
- |
|
Gold Mark Stephen |
Director |
|
2014-08-12 |
4 |
B |
$2.29 |
$45,800 |
D/D |
20,000 |
302,971 |
2.39 |
- |
|
Mandato Joseph M |
Director |
|
2014-08-08 |
4 |
A |
$2.30 |
$17,275 |
D/D |
7,500 |
37,500 |
|
- |
|
Gold Mark Stephen |
Director |
|
2014-08-08 |
4 |
B |
$2.31 |
$25,410 |
D/D |
11,000 |
282,971 |
2.39 |
- |
|
Johnston Lee Robert Jr |
Chief Financial Officer |
|
2014-06-06 |
4 |
B |
$2.55 |
$25,757 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
Zaderej Karen L. |
Chief Executive Officer |
|
2014-06-03 |
4 |
B |
$2.43 |
$12,150 |
D/D |
5,000 |
334,056 |
2.81 |
- |
|
Freitag Gregory Gene |
CFO |
|
2014-06-03 |
4 |
B |
$2.34 |
$468 |
D/D |
200 |
29,518 |
2.73 |
- |
|
Freitag Gregory Gene |
CFO |
|
2014-06-02 |
4 |
B |
$2.45 |
$12,250 |
D/D |
5,000 |
29,318 |
2.81 |
- |
|
Schiaparelli Jill F |
SVP, Bus. Strategy&Marketing |
|
2014-05-20 |
4 |
B |
$2.63 |
$5,260 |
D/D |
2,000 |
12,750 |
2.74 |
- |
|
Zaderej Karen L. |
Chief Executive Officer |
|
2014-05-12 |
4 |
B |
$2.70 |
$13,500 |
D/D |
5,000 |
329,056 |
2.81 |
- |
|
Gold Mark Stephen |
Director |
|
2014-05-07 |
4 |
B |
$2.60 |
$3,866 |
D/D |
1,487 |
271,971 |
2.31 |
- |
|
Gold Mark Stephen |
Director |
|
2014-05-06 |
4 |
B |
$2.60 |
$1,274 |
D/D |
490 |
270,484 |
2.31 |
- |
|
Mandato Joseph M |
Director |
|
2014-05-05 |
4 |
A |
$2.64 |
$39,600 |
D/D |
15,000 |
30,000 |
|
- |
|
Gold Mark Stephen |
Director |
|
2014-04-25 |
4 |
OE |
$0.27 |
$34,352 |
D/D |
17,007 |
269,994 |
|
- |
|
Zaderej Karen L. |
Chief Executive Officer |
|
2014-03-14 |
4 |
OE |
$0.27 |
$19,534 |
D/D |
72,348 |
209,222 |
|
- |
|
Zaderej Karen L. |
Chief Executive Officer |
|
2014-03-13 |
4 |
B |
$3.47 |
$5,233 |
D/D |
1,500 |
136,874 |
2.81 |
- |
|
Freitag Gregory Gene |
CFO |
|
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
38,901 |
|
- |
|
Zaderej Karen L. |
Chief Executive Officer |
|
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
135,374 |
|
- |
|
529 Records found
|
|
Page 19 of 22 |
|
|